Streptococcus pneumoniae - PowerPoint PPT Presentation

1 / 22
About This Presentation
Title:

Streptococcus pneumoniae

Description:

Microbial Pathogenesis. 40;2006;228-233. Alonsodevelasco, Verhuel, Verhoef, Snipe. Atreptococcus pneumoniae: Virulence Factors, Pathogenesis and Vaccines. – PowerPoint PPT presentation

Number of Views:357
Avg rating:3.0/5.0
Slides: 23
Provided by: coursesB
Category:

less

Transcript and Presenter's Notes

Title: Streptococcus pneumoniae


1
Streptococcus pneumoniae
  • Adele Ricciardi

2
Pneumonia-inflammatory condition of the lung
PNEUMONIA CAN BE CAUSED BY VIRUSES FUNGI BACTERIA

3
Symptoms Diagnosis
  • cough (often produces rust colored mucus)
  • fever and chills
  • shortness of breath
  • chest pain
  • fatigue
  • Chest x-ray (in hospitals and clinics)
  • Blood test
  • Sputum culture
  • physical examination
  • CT scan

4
CHEST X-RAY
5
Streptococcus pneumoniae
  • nasopharynx of healthy people
  • Gram-positive bacteria
  • Paired (diplococci) or appear in chains
  • May also infect brain (pneumococcal meningitis)
    and blood stream (pneumococcus septicemia)

Scanning Electron Micrograph of Streptococcus
pneumoniae. Source CDC/ R. Facklam, J. Carr
6
S. pneumoniae was first isolated in
1881,S. pneumoniae was first
isolated in 1881,but it still remains
the number 1 killer of children under 5
today.but it still remains the number
1 killer of children under 5 today
7
The Toll
  • 4 million deaths every year
  • half of these deaths - children under age 5
  • 5,500 children die from pneumonia every day
  • 98 of children who die of pneumonia live in
    developing countries
  • contributes to the cycle of poverty

8
S. Pneumoniae -Virulence
  • Polysaccharide capsule, gt 90 serotypes
  • Resistance to phagocytosis and antibiotics

9
Different serotypes
10
Different serotypes
11
Pneumococci in intimate contact with lung cells
show reduced capsular polysaccharide
12
Virulence- Pneumolysin
  • Toxin
  • Cholesterol-dependent cytolysin
  • Cytokine synthesis
  • Inflammatory response

13
Pneumococcal conjugate vaccine
  • Elicits antibodies against the seven most common
    capsular types
  • Sero-specific

Results Decrease nasopharyngeal
colonization Reduce disease of included serotypes
Problems Expensive Alter serotype distribution
14
Use of pneumococcal conjugate vaccine is limited
to parts of the developing world
15
Pneumonia will continue to kill
  • Unless we do something about it

16
Treatment
  • Antibiotics, lt1/dose
  • Amoxicillin inhibit cell wall formation
  • Erythromycin- inhibit protein synthesis
  • 1 out of 5 children with pneumonia receives
    antibiotics

17
We can protect from pneumonia
18
Pneumonia suffers from scientific neglect
19
(No Transcript)
20
They may not be excited now...but they will
be. This vaccine deal could save 900,000 lives by
2015.
21
(No Transcript)
22
References
  • Bruyn, G.W, Zegers, B. M, R. van Furth.
    Mechanisms of Host Defense against Infection with
    Streptococcus pneumoniae. Clinical Infections
    Diseases 199214251-62.
  • Daniels, Briles, Mirza, Hakasson, Briles. Capsule
    does not block antibody binding to PspA, a
    surface virulence protein of Streptococcus
    pneumoniae. Microbial Pathogenesis.
    402006228-233.
  • Alonsodevelasco, Verhuel, Verhoef, Snipe.
    Atreptococcus pneumoniae Virulence Factors,
    Pathogenesis and Vaccines. Microbiological
    Reviews. Dec. 1995, 591-603.
  • Hsieh, Lee, Shao, Chang, Huang. The Transforming
    Streptococcus Pneumoniae in the 21st century.
    Chang Gung Med J Vo. 30 No. 2 200831117-24
  • Hammerschmidt, Wolff, Hocke, Rosseau, Muller,
    Rohde. Illustration of Pneumonococcal
    Polysacharide Capsule during adherence and
    invasion of epithelial cells. Infection and
    Immunity. 2005 4653-4667.
  • Kadioglu, Weiser, Paton, Andrew. The role of
    streptococcus pneumoniae virulence factors in
    host respiratory colonization and disease.
    Nature. 20086.
  • World Health Organization The top 10 causes of
    death. October 2008. http//www.who.int/mediacentr
    e/factsheets/fs310/en/index.html 2 Rudan I,
    Boschi-Pinto C, Biloglav Z, Mulholland K,
    Campbell H. Epidemiology and etiology of
    childhood pneumonia. Bull World Health Organ.
    20088640816.
  • World Health Organization. World health
    statistics 2009. Geneva World Health
    Organization 2008. http//www.who.int/whosis/whos
    tat/EN_WHS09_Full.pdf
  • Rudan I, Boschi-Pinto C, Biloglav Z, Mulholland
    K, Campbell H. Epidemiology and etiology of
    childhood pneumonia. Bull World Health Organ.
    20088640816.
  • World Health Organization. World health
    statistics 2006. Geneva World Health
    Organization 2006. http//www.who.int/whosis/whos
    tat2006.pdf.
  • World Health Organization. World health
    statistics 2006. Geneva World Health
    Organization 2006. http//www.who.int/whosis/whos
    tat2006.pdf..
  • Rudan I, Boschi-Pinto C, Biloglav Z, Mulholland
    K, Campbell H. Epidemiology and etiology of
    childhood pneumonia. Bull World Health Organ.
    20088640816.
  • Rudan I, Tomaskovic L, Boschi-Pinto C, Campbell
    H. Global estimate of the incidence of clinical
    pneumonia among children under five years of age.
    Bull World Health Organ. 200482895903.
Write a Comment
User Comments (0)
About PowerShow.com